FUREN Group Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 3,833.508 million compared to CNY 4,767.554 million a year ago. Operating income was CNY 692.441 million compared to CNY 903.020 million a year ago. Net income was CNY 539.850 million compared to CNY 730.980 million a year ago. Basic earnings per share from continuing operations was CNY 0.86 compared to CNY 1.17 a year ago.